e-learning
resources
Paris 2018
Sunday, 16.09.2018
Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
IMPACT OF OMALIZUMAB ON ALLERGIC ASTHMA - THE LAST 10 YEAR
M. Araújo Pereira (Braga, Portugal), I. Ladeira (Porto, Portugal), R. Lima (Porto, Portugal), I. Franco (Porto, Portugal), I. Pascoal (Porto, Portugal), A. Carvalho (Porto, Portugal)
Source:
International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Session:
Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Session type:
Thematic Poster
Number:
1127
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Araújo Pereira (Braga, Portugal), I. Ladeira (Porto, Portugal), R. Lima (Porto, Portugal), I. Franco (Porto, Portugal), I. Pascoal (Porto, Portugal), A. Carvalho (Porto, Portugal). IMPACT OF OMALIZUMAB ON ALLERGIC ASTHMA - THE LAST 10 YEAR. 1127
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Late Breaking Abstract - RHEOLOGY AS A TOOL TO ASSESS COPD DIAGNOSIS COMPARED TO ASTHMA DIAGNOSIS, AND TO EVALUATE THE EFFICIENCY OF TREATMENTS
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017
THE IMPACT OF REFLEXOLOGY AND HOMEOPATHY ADDED TO CONVENTIONAL ASTHMA TREATMENT ON MARKERS OF AIRWAY INFLAMMATION– A RANDOMISED STUDY
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
PREVALENCE AND SOCIOECONOMIC ASSOCIATIONS OF ASTHMA AND ALLERGIC RHINITIS IN NORTHERN AFRICA.
Source: Eur Respir J 2006; 28: 1292
Year: 2006
Late Breaking Abstract - ORAL FORMULATION OF ANGIOTENSIN-(1-7) PROMOTES RESOLUTION OF EOSINOPHILIC AND NEUTROPHILIC INFLAMMATION IN AN EXPERIMENTAL ASTHMA MODEL
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
DIFFERENCES IN HOSPITAL COURSE IN COMMUNITY ACQUIRED PNEUMONIA (CAP) ACCORDING TO ANTIBIOTIC TREATMENT
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
AWAKE PRONE POSITION IN CRITICAL AND SEVERE COVID-19 PATIENTS UNDERGOING NONINVASIVE RESPIRATORY SUPPORT: A RETROSPECTIVE MULTICENTER COHORT STUDY.
Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19
Year: 2021
SCREENING FOR UNDERDIAGNOSED CHILDHOOD ASTHMA IN BATUMI (GEORGIA)
Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases
Year: 2020
CHARACTERIZATION AND SURVIVAL OF PATIENTS WITH SPINAL MUSCLE ATROPHY TYPE 1 ON HOME MECHANICAL VENTILATION PROGRAM OF MINISTRY OF HEALTH, CHILE
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017
BRONCHIOLITIS IN INFANCY IS AN IMPORTANT RISK FACTOR FOR ASTHMA BUT NOT FOR ALLERGIC SENSITIZATION AT AGE 6
Source: International Congress 2019 – Asthma biomarkers, diagnostics and risk factors
Year: 2019
VENTILATORY MUSCLE STRENGTH SIX MONTHS AFTER CORONARY ARTERY BYPASS GRAFTING IN PATIENTS SUBMITTED TO INSPIRATORY MUSCULAR TRAINING BASED ON THE ANAEROBIOSIS THRESHOLD: CLINICAL TRIAL
Source: Virtual Congress 2021 – An update on respiratory physiotherapy and respiratory muscle function and training
Year: 2021
IMPACT OF COMORBIDITY ON DIRECT MEDICAL COSTS OF COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017
INSPIRATORY MUSCLE TRAINING BASED ON THE ANAEROBIOSIS THRESHOLD ON THE FUNCTIONAL CAPACITY OF PATIENTS SUBMITTED TO CORONARY ARTERIAL BYPASS GRAFTING: RANDOMIZED AND CONTROLLED CLINICAL TRIAL
Source: International Congress 2019 – Cardiopulmonary exercise testing
Year: 2019
ONE YEAR MORTALITY IN PATIENTS WITH PNEUMOCOCCAL BACTERAEMIC COMMUNITY ACQUIRED PNEUMONIA: ROLE OF THREE PNEUMONIA SEVERITY SCORES
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017
LYMPHANGIOLEIOMYOMATOSIS AND SIROLIMUS: MEDIUM-TERM IMPACT ON PULMONARY FUNCTION
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021
PROTEOMIC ANALYSIS OF BLOOD SERUM OF CHILDREN WITH BRONCHIAL ASTHMA
Source: International Congress 2019 – Asthma biomarkers, diagnostics and risk factors
Year: 2019
IMPACT OF NON-INVASIVE VENTILATION IMMEDIATELY AFTER EXTUBATION ON CLINICAL AND FUNCTIONAL OUTCOMES IN PATIENTS SUBMITTED TO CORONARY ARTERY BYPASS GRAFTING: CLINICAL TRIAL
Source: Virtual Congress 2021 – An update on respiratory physiotherapy and respiratory muscle function and training
Year: 2021
CARACTERISTICS OF A PROSPECTIVE COHORT OF PATIENTS WITH IPAF (INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES) BY NEUMOLOGISTS AND REUMATOLOGISTS OF MADRID. IPAF-NEREM STUDY
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
IMPACT OF A COMMUNITY-BASED EXERCISE PROGRAM ON PULMONARY FUNCTION IN MIDDLE-AGE AND OLDER PATIENTS WITH TYPE 2 DIABETES
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017
FOLLOW-UP OF OBSTRUCTIVE SLEEP APNEA TREATMENT: DIFFICULTIES FACED BY PRIMARY CARE UNITS
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020
A STUDY OF CLINICORADIOLOGICAL AND MICROBIOLOGICAL PROFILE AND BIOMARKERS IN CASES OF COMMUNITY ACQUIRED PNEUMONIA ADMITTED IN A TERTIARY CARE HOSPITAL
Source: Virtual Congress 2021 – Pneumonia
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept